PharmaSGP's Chemical-Free OTCs A Hit With EU Consumers During COVID-19
Executive Summary
Germany's PharmaSGP reported solid sales gains in the first half as European consumers snapped up its chemical-free OTCs and dietary supplement offering.
You may also be interested in...
GSK Offloads Popular German OTCs To PharmaSGP
GSK divests non-core German OTC portfolio to local player PharmaSGP, which says it has gained "established brands" in the pain-relief and sleep-aid categories.
Sweden Seeks To Tackle Opioid Overdose Deaths With Naloxone Rx-To-OTC Switch
Opioid antagonist naloxone will soon be available without prescription in Sweden following a successful Rx-to-OTC application from Norway's DNE Pharma.
Norway's Orkla Prioritizes Seeing Off Private-Label Consumer Health Challenge
Alongside addressing the threat posed by private-label, Orkla Health CEO Isabelle Ducellier will over the coming three years focus on building global brands and simplifying the value chain to improve efficiency and extract synergies.